Host: Malcolm G. Munro MD, FRCS(c), FACOG Guest: Michael Auerbach, MD This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm M

Host: Malcolm G. Munro MD, FRCS(c), FACOG Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in you

Host: Malcolm G. Munro MD, FRCS(c), FACOG Guest: Michael Auerbach, MD This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm M

Host: Malcolm G. Munro MD, FRCS(c), FACOG Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in you

Host: Malcolm G. Munro MD, FRCS(c), FACOG Guest: Arjeme Denise Cavens, MD This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malco

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Roberto Romero, MD, DMedSci Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms

Host: Arjeme Denise Cavens, MD Guest: Lee Shulman MD, FACOG, FACMG This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro

Host: Mazen Noureddin, MD Nonalcoholic steatohepatitis (NASH) is an epidemic with enormous health and economic implications. Join us for our chairmans perspective on best practices to identify, screen, and refer patients. Dr. Mazen Noureddin al

Host: Helena Yu, MD Guest: Makenzi Evangelist, MD This Expert Exchange webcast is designed to enhance clinicians awareness of the function and role of HER3 in emerging treatment strategies for non-small cell lung cancer and metastatic breas

Host: Hope S. Rugo, MD, FASCO Guest: Peter Schmid, FRCP, MD, PhD HR+/HER2- breast cancer accounts for approximately 70% of early breast cancer. Now that the CDK4/6 inhibitor abemaciclib has been approved in the United States and internationa